about
Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals.Hepatitis C Treatment and Barriers to Eradication.Access to medicines and hepatitis C in Africa: can tiered pricing and voluntary licencing assure universal access, health equity and fairness?Hepatitis C infection and chemotherapy toxicity.The Burden of Primary Liver Cancer and Underlying Etiologies From 1990 to 2015 at the Global, Regional, and National Level: Results From the Global Burden of Disease Study 2015.Predictable threats to public health through delaying universal access to innovative medicines for hepatitis C: a pharmaceutical standpointTowards supporting greater and lower cost access to direct acting antiviral treatment for hepatitis C for all patientsNeed of righteous attitudes towards eradication of hepatitis C virus infection in Latin America.Proteases and protease inhibitors in infectious diseases.
P2860
Q37735774-B217BC64-57EE-4449-9DEA-B66789BA7F06Q38961563-DE1A2C9C-0E3E-4ABC-9203-985020C87114Q40042851-05733FA2-CB05-495C-88B7-4F15CCCE4153Q41918877-0C5527D0-5A00-4A9A-8D80-D6949653A7C5Q41923187-90C9105B-F9B4-42E5-A31A-65EDA0CF61EEQ42329781-B6A371D7-FE2C-4157-9953-727207A11D2AQ42341077-D7B2FE4C-EBAE-49EB-900B-321CD91431FDQ42741292-CEDC1455-BBE9-4880-BC68-5876ABC1CF3BQ47576680-D3D1E4AA-CFF1-429C-B3A1-108BCA661107
P2860
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Access to hepatitis C medicines.
@ast
Access to hepatitis C medicines.
@en
type
label
Access to hepatitis C medicines.
@ast
Access to hepatitis C medicines.
@en
prefLabel
Access to hepatitis C medicines.
@ast
Access to hepatitis C medicines.
@en
P2093
P2860
P356
P1476
Access to hepatitis C medicines.
@en
P2093
Danny J Edwards
Delphi Gm Coppens
Jayasree K Iyer
Laurien A Rook
Tara L Prasad
P2860
P304
P356
10.2471/BLT.15.157784
P407
P577
2015-10-08T00:00:00Z